CMS (00867): Li Xianliang was appointed as an independent non-executive director.
KPC Pharmaceuticals (00867) announces that Mr. Li Xianliang has been appointed as an independent non-executive director, effective from June 29, 2026.
CMS(00867) announced that Mr. Li Xianliang has been appointed as an independent non-executive director, effective from June 29, 2026.
Related Articles
AK MEDICAL purchased 1.382 million shares at a cost of 7.1632 million Hong Kong dollars on June 29th.
SANG HING HLDGS (01472) announced its annual performance with a net loss attributable to shareholders of HK$11.649 million, a 28.1% increase compared to the previous year.
Scholar Edu (01769)The trustee purchased 457,000 shares under the stock incentive plan.
AK MEDICAL purchased 1.382 million shares at a cost of 7.1632 million Hong Kong dollars on June 29th.
SANG HING HLDGS (01472) announced its annual performance with a net loss attributable to shareholders of HK$11.649 million, a 28.1% increase compared to the previous year.
Scholar Edu (01769)The trustee purchased 457,000 shares under the stock incentive plan.
RECOMMEND
